Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124164088 | 12416408 | 8 | F | 2016 | 20160630 | 20160530 | 20160712 | EXP | PHHY2016CA000997 | SANDOZ | 0.00 | F | Y | 0.00000 | 20160713 | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124164088 | 12416408 | 1 | SS | COSENTYX | SECUKINUMAB | 1 | Subcutaneous | 300 MG, QMO | 0 | 300 | MG | INJECTION | /month | ||||||
| 124164088 | 12416408 | 2 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 10 MG, UNK | U | 76859 | 10 | MG | |||||||
| 124164088 | 12416408 | 3 | I | IRBESARTAN. | IRBESARTAN | 1 | Unknown | 300 MG, UNK | U | 0 | 300 | MG | |||||||
| 124164088 | 12416408 | 4 | I | ATENOLOL. | ATENOLOL | 1 | Unknown | 50 MG, UNK | U | 0 | 50 | MG | |||||||
| 124164088 | 12416408 | 5 | I | TRIAMTERENE. | TRIAMTERENE | 1 | Unknown | 50 MG, UNK | U | 0 | 50 | MG | |||||||
| 124164088 | 12416408 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 124164088 | 12416408 | 7 | C | RABEPRAZOLE SODIUM. | RABEPRAZOLE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 124164088 | 12416408 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | U | 0 | ||||||||||
| 124164088 | 12416408 | 9 | C | COAL TAR. | COAL TAR | 1 | Topical | U | 0 | ||||||||||
| 124164088 | 12416408 | 10 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 124164088 | 12416408 | 11 | C | CALCIUM | CALCIUM | 1 | Unknown | U | 0 | ||||||||||
| 124164088 | 12416408 | 12 | C | OMEGA-3 FATTY ACIDS | OMEGA-3 FATTY ACIDS | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124164088 | 12416408 | 1 | Psoriasis |
| 124164088 | 12416408 | 2 | Product used for unknown indication |
| 124164088 | 12416408 | 3 | Product used for unknown indication |
| 124164088 | 12416408 | 4 | Product used for unknown indication |
| 124164088 | 12416408 | 5 | Product used for unknown indication |
| 124164088 | 12416408 | 6 | Product used for unknown indication |
| 124164088 | 12416408 | 7 | Abdominal discomfort |
| 124164088 | 12416408 | 8 | Product used for unknown indication |
| 124164088 | 12416408 | 9 | Product used for unknown indication |
| 124164088 | 12416408 | 10 | Product used for unknown indication |
| 124164088 | 12416408 | 11 | Product used for unknown indication |
| 124164088 | 12416408 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124164088 | 12416408 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124164088 | 12416408 | Burning sensation | |
| 124164088 | 12416408 | Contusion | |
| 124164088 | 12416408 | Depressed mood | |
| 124164088 | 12416408 | Drug ineffective | |
| 124164088 | 12416408 | Drug interaction | |
| 124164088 | 12416408 | Feeling abnormal | |
| 124164088 | 12416408 | Fungal infection | |
| 124164088 | 12416408 | General physical health deterioration | |
| 124164088 | 12416408 | Injection site pain | |
| 124164088 | 12416408 | Limb discomfort | |
| 124164088 | 12416408 | Nasopharyngitis | |
| 124164088 | 12416408 | Pain | |
| 124164088 | 12416408 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124164088 | 12416408 | 1 | 20151230 | 0 |